BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210916T160000
DTEND;TZID=Europe/Stockholm:20210916T170000
DTSTAMP:20260419T153020
CREATED:20210826T102829Z
LAST-MODIFIED:20210826T142827Z
UID:27453-1631808000-1631811600@senzagen.com
SUMMARY:Webinar: How is GARD used for skin sensitization testing?
DESCRIPTION:User cases on hazard and potency assessment\nGiven the huge interest in our previous webinar on GARD user cases\, we are pleased to offer you a new opportunity to hear how our customers use GARD to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. \n\nKey topics\nWe will provide several user cases on how the GARD assays have been used for skin sensitization testing to demonstrate: \n\nHazard assessment of “difficult-to-test” samples such as complex mixtures and surfactants.\nSensitization information for risk assessment of medical devices and solid materials.\nPotency determination for both CLP classification and product development.\n\nThe webinar should last around 40 minutes\, followed by a live Q&A. If you cannot attend the live event\, register now to get access to the recording of this webinar. \nSpeakers\n  \n\nRegister now
URL:https://senzagen.com/event/new-opportunity-how-is-gard-used-for-sensitization-testing/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2021/08/webinar-banner-cropped.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210601T160000
DTEND;TZID=Europe/Stockholm:20210601T170000
DTSTAMP:20260419T153020
CREATED:20210525T093936Z
LAST-MODIFIED:20210525T094123Z
UID:27136-1622563200-1622566800@senzagen.com
SUMMARY:SaferWorldbyDesign Webinar: A novel in vitro approach for quantitative assessment of skin sensitizing potency
DESCRIPTION:This presentation will introduce GARDskin Dose-Response assay\, a novel approach for the assessment of relative skin sensitizing potency on a continuous scale. \nResults demonstrate that induction of toxicity pathways in GARDskin Dose-Response appears to be highly dose-dependent\, and the lowest concentration required to induce a positive classification in the assay correlates strongly and significantly with both LLNA EC3 and human NOEL values. \nA case study will be used to illustrate how the experimentally derived values from the GARDskin Dose-response assay can be used for CLP potency assessments\, potency rankings of potential candidate molecules\, or as a point of departure for quantitative risk assessment without having to revert to animal experimentation. \nFeatured Speakers\n\nAndy Forreryd\, PhD \nDr Andy Forreryd holds a Master of Science in molecular biotechnology from the Faculty of Engineering LTH at Lund University and a Doctor of philosophy in Immunotechnology from Lund University. He has many years of experience working with in vitro assay development\, genomics\, and machine learning. He is co-developer of the GARD® platform for the assessment of chemical sensitizers and inventor of two patents related to the technology. \n  \nRead more and register here
URL:https://senzagen.com/event/saferworldbydesign-webinar-a-novel-in-vitro-approach-for-quantitative-assessment-of-skin-sensitizing-potency/
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR